Anupam Rasayan India Ltd. · NSE:ANURAS
Anupam Rasayan India — Q4 FY24 Earnings Presentation
27 slides from Anupam Rasayan India's earnings presentation, May 18, 2024
Slide 1: Cover letter to stock exchanges: Investor Presentation
ANUPAM RASAYAN INDIA LTD. R ARILSLDSTX20240518013 Date: May 18, 2024 To, To, BSE Limited, National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, ‘Exchange Plaza’, C-1, Block-G, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai -400001, India Mumbai 400051, India SCRIP CODE: 5432
Slide 2: Anupam Rasayan India Limited Q4FY24 & FY2024
Anupam Rasayan India Limited Q4FY24 & FY2024 May 2024
Slide 3: Quarterly Highlights
Quarterly Highlights 1 2 Anupam Rasayan India Limited \
Slide 4: Quarterly Financial Highlights
3 Quarterly Financial Highlights \ Limited India Consolidated EBITDA (Incl. Consolidated PAT stood Rasayan Consolidated Total Revenue was ₹ 4,130 Mn; Other Revenue) was ₹ 1,047 at ₹ 405 Mn., margin Y-o-Y de-growth of 18% Mn.; margin stands at 25% stands at 10% Anupam Standalone Total Revenue Standal
Slide 5: Managing Director's Message
4 Managing Director’s Message \ Limited “Indian chemical industry including spec chem industry has faced significant headwinds India during the last year. However, despite the de-growth in the top-line, we have been able to sustain our profitability and maintain margins at 27% levels on a full year
Slide 6: Operational Updates
5 Operational Updates \ Limited India Commercialization of New Molecules – In Q4FY24, 6 new molecules were commercialized taking total to 17 new molecules Rasayan launched in FY24. Of the total 6 molecules, 5 molecules are from fluorination series. Anupam Capex Incurred – Company incurred capex of ₹
Slide 7: Consolidated Profit & Loss Summary (Quarterly)
6 QUARTERLY FINANCIALS Consolidated Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) Q4FY24 Q4FY23 INCOME India Revenue from Operations 4,010 4,800 Other Income 120 243 Total Revenue Rasayan 4,130 5,042 Total Revenue Growth (%) (18%) EXPENSES: Cost of Raw Materials Consumed Anupam 1,879 2,3
Slide 8: Standalone Profit & Loss Summary (Quarterly)
7 QUARTERLY FINANCIALS Standalone Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) Q4FY24 Q4FY23 INCOME India Revenue from Operations 3,085 3,713 Other Income 111 180 Total Revenue 3,195 3,893 Rasayan Total Revenue Growth (%) (18%) EXPENSES: Cost of Raw Materials Consumed 1,353 1,735 Anupam
Slide 9: Consolidated Profit & Loss Summary (Yearly)
8 YEARLY FINANCIALS Consolidated Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) FY24 FY23 INCOME India Revenue from Operations 14,751 16,019 Other Income 302 86 Total Revenue 15,053 16,105 Rasayan Total Revenue Growth (%) (7%) EXPENSES: Cost of Raw Materials Consumed 6,144 7,036 Anupam Gr
Slide 10: Standalone Profit & Loss Summary (Yearly)
9 YEARLY FINANCIALS Standalone Profit & Loss Summary \ Limited (All amounts are in ₹ Mn) FY24 FY23 INCOME India Revenue from Operations 11,287 12,841 Other Income 259 22 Total Revenue 11,546 12,863 Rasayan Total Revenue Growth (%) (10%) EXPENSES: Cost of Raw Materials Consumed 4,264 5,134 Anupam Gro
Slide 11: Business Overview
Business Overview 2 10 Anupam Rasayan India Limited \
Slide 12: Company at a glance
11 Innovating Sustainable & Custom Solutions for Global Markets \ Limited Company at a glance India Established Custom Specializes in multi-step Catering to globally Strong supply chain Synthesis player with 40 synthesis undertaking relevant chemical & with backward Rasayan years of track record com
Slide 13: Evolution of Anupam Rasayan
12 Evolution of \ Phase II- Limited Phase I-Inception Anupam The Acceleration India • Raised ₹5,000 mn. through QIP Formed Rasayan • Commissioned Solar partnership firm Power Plant of 5.4MW “Anupam Rasayan” at Bharuch • Fast growing Anupam Specialty Chemical Acquired ~26% Manufacturer with Started s
Slide 14: Chemical Conduits and Global Partnerships
13 Chemical Conduits and Global Partnerships \ Limited India Business Verticals Overview Few of our top global clients Rasayan Life Science Related Other Specialty Specialty Chemicals Chemicals Agrochemicals Anupam (including Crop Protection) Specialty Pigments Manufacturing agro intermediates and a
Slide 15: Charting New Frontiers with R&D Excellence
14 Charting New Frontiers with R&D Excellence \ Limited Process technologies deployed India Flow Chemistry Photo Chemistry • Reduced lead time • Simplified Rasayan • Material efficient & synthesis of cost benefits complex molecules • Lesser • Larger potential for environmental automation impacts in
Slide 16: Experienced Leadership & Deep Technical Talent Pool
15 Experienced Leadership & Deep Technical Talent Pool \ Limited India Mr. Anand S Desai Mrs. Mona A Desai Rasayan Managing Director Vice-chairman & Whole-time Director Over 30 years of experience in chemicals Over 20 years of experience in chemicals industry associated with company since 1992 & ind
Slide 17: Expanded Business Development Team Globally
16 Expanded Business Development Team Globally \ Limited Europe United States India Mr. Thierry Baumlin Mr. Pierre Joris Mr. John Grant Rasayan Key Account Manager - Business Advisor - Business Advisor - Crop Protection Specialty Fluoro Chemicals Specialty Fluoro Chemicals 30 years+ of experience in
Slide 18: Growth Drivers
Drivers Growth 3 17 Anupam Rasayan India Limited \
Slide 19: Growth Drivers
18 Growth Drivers \ Limited India Rasayan 1 2 3 Anupam Growth of Execution of Expansion in Polymer and Signed LOIs and Fluorination Pharma Product Contracts chemistry Portfolio
Slide 20: Growth of Pharma and Polymer Portfolio
19 Growth of Pharma and Polymer Portfolio \ Limited New Strategic Custom 55+ 9+ India Development Products under pipeline to be manufactured by Number of molecules of Number of molecules in Rasayan Anupam in India: pharma and polymer in pharma and polymer R&D and pilot commercialized in FY24 Anupam
Slide 21: Pharma Segment Expansion
20 Pharma Segment Expansion \ Limited …and are targeting a large ~$15B TAM We have made significant progress in Pharma … with significant growth India Rasayan Focus segment for Anupam: High-value KSM/intermediates 10+ Anupam 25+ molecules Leading Pharma commercialized players serviced (over the past
Slide 22: Made Strides Into Polymer Chemicals
21 Made Strides Into Polymer Chemicals \ Limited Forayed into polymer by working with leading global …across major emerging applications innovators … with a ~$10B growing TAM India Rasayan 2 Leading Anupam global innovators ~$10B ~4% High-value Polymer being serviced CAGR Chemicals To t a l A d d r
Slide 23: Strong Order Book – Recent LOI/Contracts Signed
22 Strong Order Book – Recent LOI/Contracts Signed \ Limited Signing Quarter Segment Customer LOI/Contract Tenor (Years) Value(₹ Crores) India Q1FY22 Life Science Multinational Life Science Company LOI 5 ₹1,100 Q1FY22 Life Science Two Multinational Companies Contract 5 ₹540 Rasayan Q2FY22 Life Scien
Slide 24: Strategic Expansion in Fluorination with Tanfac
23 Anupam’s Strategic Expansion in Fluorination with Tanfac \ Limited Anupam acquired ~26% stake in India Tanfac for ~₹1,530M in May'22 Rasayan Producer of Leading Anupam fluorinated producer of intermediates KF/HF • Specialty fluoride chemical Anupam Tanfac manufacturer in India Only Indian • Leadi
Slide 25: Expansion in Fluorination Chemistry
24 Expansion in Fluorination Chemistry \ Limited FOCUSED SEGMENTS MOLECULES END APPLICATION CUSTOMER SEGMENT REVENUE India POTENTIAL Product A Elastomer US MNC Rasayan Polymers $ 40 – 70 Mn. Product B Semiconductor/Flame Retardant Japanese MNC Anupam Product X/Y Cardio/Anti-viral Indian MNC Pharmace
Slide 26: Summary: Strengths and Key Highlights
25 Summary \ Limited Strengths and Key Highlights India • Doubled manufacturing capacity in the last three years Rasayan Manufacturing • Strong capex plans to expand capacity into newer Prowess molecules / chemistries Anupam R&D • DSIR recognized R&D center with a team of 88 R&D professionals Capabi
Slide 27: Thank You
Corporate Office ANUPAM Anupam Rasayan India Ltd. India (HQ) 10th Floor, Icon Rio, Dumas Road, Surat, Gujarat, RASAYAN INDIA India – 395 007 LIMITED ThankYou BSE: 543275 | NSE: ANURAS | ISIN: INE930P01018 ©2022 – Anupam Rasayan India Limited, All Rights Reserved. DRAFT